Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medic......READ MORE
expert roundtables by Kenneth C. Anderson, MD; Sagar Lonial, MD, FACP; and S. Vincent Rajkumar, MD
With the ultimate goal of having a cure for multiple myeloma, researchers and clinicians hope to assemble strategies that will incorporate new and ......READ MORE
expert roundtables by Kenneth C. Anderson, MD; Sagar Lonial, MD, FACP; and S. Vincent Rajkumar, MD
Chimeric antigen receptor (CAR) T-cell therapy can achieve very high response rates in heavily pretreated multiple myeloma, allowing many patients ......READ MORE
patient care perspectives by Michael C. Heinrich, MD
The risk of recurrence, growth, and spread of gastrointestinal stromal tumors (GIST) after surgery relates to key variables such as the size, locat......READ MORE
patient care perspectives by S. Vincent Rajkumar, MD
The management of multiple myeloma is evolving with the emergence of new agents and new approaches to treatment. The paradigm is shifting in severa......READ MORE
High-risk and ultra-high-risk multiple myeloma, characterized by the presence of cytogenetic abnormalities and/or extramedullary disease, represent......READ MORE
patient care perspectives by Kenneth C. Anderson, MD
Since the manufacturing of chimeric antigen receptor (CAR) T-cell therapy takes time, bridging therapy is often delivered to ensure that the diseas......READ MORE
